Progress towards therapies for disease modification in Parkinson's disease

None of treatments investigated to date have yet translated into a clinically proven disease-modifying treatment. Review explores reasons for this, noting that until past 5–10 years researchers have selected therapeutic candidates on basis of unrepresentative preclinical models.

Source:

The Lancet Neurology